Saffron, a herbal medicine for alteration of depression and serum lipids.
Phase 2
- Conditions
- Major depression.Severe depressive episode without psychotic symptoms
- Registration Number
- IRCT2013110915334N1
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
diagnosed major depression; no lipid lowering medicine or depression treatment in last 6 months; informed consent; age between 18-55 years.
Exclusion criteria: history of suicide; presence of chronic disease such as metabolic disease and cancer; presence of ideas of suicide.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depressive status. Timepoint: at the beginning, 4th and 6th week of treatment. Method of measurement: Beck questionnaire.
- Secondary Outcome Measures
Name Time Method Serum lipids. Timepoint: at the beginning and at the end of study. Method of measurement: laboratory.